- Home
- FLR vs CRL Comparison
FLR vs CRL Comparison
Compare FLR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLR
- CRL
- Stock Information
- Founded
- FLR 1912
- CRL 1947
- Country
- FLR United States
- CRL United States
- Employees
- FLR N/A
- CRL N/A
- Industry
- FLR Military/Government/Technical
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FLR Industrials
- CRL Health Care
- Exchange
- FLR Nasdaq
- CRL Nasdaq
- Market Cap
- FLR 7.2B
- CRL 7.3B
- IPO Year
- FLR N/A
- CRL 2000
- Fundamental
- Price
- FLR $43.03
- CRL $168.87
- Analyst Decision
- FLR Buy
- CRL Buy
- Analyst Count
- FLR 7
- CRL 16
- Target Price
- FLR $50.57
- CRL $189.50
- AVG Volume (30 Days)
- FLR 3.3M
- CRL 969.1K
- Earning Date
- FLR 11-07-2025
- CRL 11-05-2025
- Dividend Yield
- FLR N/A
- CRL N/A
- EPS Growth
- FLR 970.51
- CRL N/A
- EPS
- FLR 24.07
- CRL N/A
- Revenue
- FLR $16,313,000,000.00
- CRL $4,028,615,000.00
- Revenue This Year
- FLR $3.29
- CRL N/A
- Revenue Next Year
- FLR $4.33
- CRL $2.11
- P/E Ratio
- FLR $1.78
- CRL N/A
- Revenue Growth
- FLR 3.61
- CRL N/A
- 52 Week Low
- FLR $29.20
- CRL $91.86
- 52 Week High
- FLR $60.10
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- FLR 50.07
- CRL 58.51
- Support Level
- FLR $42.53
- CRL $144.26
- Resistance Level
- FLR $44.62
- CRL $181.45
- Average True Range (ATR)
- FLR 1.54
- CRL 5.77
- MACD
- FLR 0.21
- CRL 2.58
- Stochastic Oscillator
- FLR 49.80
- CRL 66.93
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.